3D Systems (DDD) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
22 May, 2026Company overview and business model
Markets 3D printing and digital manufacturing solutions globally, serving Healthcare and Industrial sectors.
Offers 3D printers for plastics and metals, materials, software, and services including maintenance and engineering.
Operates through subsidiaries in the Americas, EMEA, and APAC regions.
Over 35 years of experience in developing end-to-end digital workflow solutions.
Financial performance and metrics
Financial statements for 2023–2025 audited by Deloitte & Touche LLP and BDO USA, P.C., with unqualified opinions on financials and adverse opinion on internal controls as of 2025.
As of May 4, 2026, 146,947,053 shares of common stock outstanding; no preferred stock outstanding.
Common stock last traded at $2.99 per share on May 21, 2026, on the NYSE.
Use of proceeds and capital allocation
Net proceeds expected to finance future acquisitions, working capital, general corporate purposes, and potential debt repayment or repurchase.
Specific allocation of proceeds to be detailed in each prospectus supplement.
Latest events from 3D Systems
- Revenue fell 8% YoY, net loss widened, but cost actions and asset sale strengthened liquidity.DDD
Q1 20259 Jul 2026 - Sequential revenue growth and margin gains offset year-over-year declines; outlook remains positive.DDD
Q2 20248 Jul 2026 - 2024 revenue hit $440M; cost cuts and Geomagic sale target break-even EBITDA by Q4 2025.DDD
Q4 20248 Jul 2026 - Revenue up 11%, Healthcare surged 21%, and EBITDA turned positive on higher gross margin.DDD
Q1 202612 May 2026 - Board urges approval of all proposals, emphasizing the Equity Plan's role in talent retention.DDD
Proxy filing30 Apr 2026 - Proxy covers director elections, compensation, auditor, share increase, and incentive plan changes.DDD
Proxy filing8 Apr 2026 - Proxy seeks approval for board elections, compensation, auditor, share increase, and incentive plan.DDD
Proxy filing26 Mar 2026 - Q4 2025 saw 16% sequential growth, margin gains, and $55M in cost savings, led by key segments.DDD
Q4 20259 Mar 2026 - FDA-approved 3D printed dentures and aerospace growth position the business for major expansion.DDD
28th Annual Needham Growth Conference Virtual13 Jan 2026